Cargando…

Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis

Chronic kidney disease (CKD) is a global health burden with a high economic cost to health systems and is an independent risk factor for cardiovascular disease (CVD). All stages of CKD are associated with increased risks of cardiovascular morbidity, premature mortality, and/or decreased quality of l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hill, Nathan R., Fatoba, Samuel T., Oke, Jason L., Hirst, Jennifer A., O’Callaghan, Christopher A., Lasserson, Daniel S., Hobbs, F. D. Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934905/ https://www.ncbi.nlm.nih.gov/pubmed/27383068 http://dx.doi.org/10.1371/journal.pone.0158765

Ejemplares similares

The Oxford Renal (OxRen) cross-sectional study of chronic kidney disease in the UK
por: Hill, Nathan R, et al.
Publicado: (2013)

Prevalence of chronic kidney disease in the community using data from OxRen: a UK population-based cohort study
por: Hirst, Jennifer A, et al.
Publicado: (2020)

Trends in kidney function testing in UK primary care since the introduction of the quality and outcomes framework: a retrospective cohort study using CPRD
por: Feakins, Benjamin, et al.
Publicado: (2019)

Long-term health outcomes of people with reduced kidney function in the UK: A modelling study using population health data
por: Schlackow, Iryna, et al.
Publicado: (2020)

Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting
por: O'Callaghan, Christopher A, et al.
Publicado: (2011)

Statistical models for the deterioration of kidney function in a primary care population: A retrospective database analysis
por: Oke, Jason L, et al.
Publicado: (2022)

Effects of antihypertensives, lipid-modifying drugs, glycaemic control drugs and sodium bicarbonate on the progression of stages 3 and 4 chronic kidney disease in adults: a systematic review and meta-analysis
por: Taylor, Kathryn S, et al.
Publicado: (2019)

Prevalence and factors associated with multimorbidity among primary care patients with decreased renal function
por: Hirst, Jennifer A., et al.
Publicado: (2021)

Quality of life in older adults with chronic kidney disease and transient changes in renal function: Findings from the Oxford Renal cohort
por: Busa, Isabella, et al.
Publicado: (2022)

A retrospective analysis of outcomes in low- and intermediate–high-risk pulmonary embolism patients managed on an ambulatory medical unit in the UK
por: Reschen, Michael E., et al.
Publicado: (2019)

Impact of the COVID-19 pandemic on emergency department attendances and acute medical admissions
por: Reschen, Michael E., et al.
Publicado: (2021)

What is the relationship between renal function and visit-to-visit blood pressure variability in primary care? Retrospective cohort study from routinely collected healthcare data
por: Lasserson, Daniel S, et al.
Publicado: (2016)

Trends in serum creatinine testing in Oxfordshire, UK, 1993–2013: a population-based cohort study
por: Oke, Jason, et al.
Publicado: (2015)

The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis
por: Whitlock, Reid, et al.
Publicado: (2023)

Prevalence and global trends of polypharmacy in patients with chronic kidney disease: A systematic review and meta-analysis
por: Naseralallah, Lina, et al.
Publicado: (2023)

Towards gene therapy for primary ciliary dyskinesia
por: Munye, M, et al.
Publicado: (2012)

Change in glomerular filtration rate over time in the Oxford Renal Cohort Study: observational study
por: Hirst, Jennifer A, et al.
Publicado: (2022)

Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial–a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial
por: Hill, Nathan R, et al.
Publicado: (2014)

OxMaR: Open Source Free Software for Online Minimization and Randomization for Clinical Trials
por: O’Callaghan, Christopher A.
Publicado: (2014)

Biology—The Path Ahead
por: O’Callaghan, Christopher A.
Publicado: (2011)

n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney Disease
por: Barden, Anne, et al.
Publicado: (2016)

Correction: Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial–a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial
por: Hill, Nathan R., et al.
Publicado: (2022)

Intracerebroventricular antisense knockdown of Gα(i2 )results in ciliary stasis and ventricular dilatation in the rat
por: Mönkkönen, Kati S, et al.
Publicado: (2007)

Prevalence of and risk factors for chronic kidney disease of unknown aetiology in India: secondary data analysis of three population-based cross-sectional studies
por: O’Callaghan-Gordo, Cristina, et al.
Publicado: (2019)

Ciliated conical epithelial cell protrusions point towards a diagnosis of primary ciliary dyskinesia
por: O’Callaghan, Chris, et al.
Publicado: (2018)

Impact on cardiovascular risk follow-up from a shift to the CKD-EPI formula for eGFR reporting: a cross-sectional population-based primary care study
por: van Gelder, Vincent A, et al.
Publicado: (2013)

Meeting Report from “Frontiers in Nutritional Science: Nutritional Metabolomics”
por: O’Callaghan, Nathan, et al.
Publicado: (2014)

Impact of a single eGFR and eGFR-estimating equation on chronic kidney disease reclassification: a cohort study in primary care
por: Hirst, Jennifer A, et al.
Publicado: (2018)

A quantitative PCR method for measuring absolute telomere length
por: O'Callaghan, Nathan J, et al.
Publicado: (2011)

Seminal papers in urology: anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence
por: Shugg, Nathan, et al.
Publicado: (2023)

Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania
por: Janmohamed, Mubarakali N, et al.
Publicado: (2013)

Characterization of aminopeptidase N from Torpedo marmorata kidney
por: O'Callaghan, Barbara, et al.
Publicado: (2012)

CKD of Unknown Cause: A Global Epidemic?
por: Pearce, Neil, et al.
Publicado: (2018)

MetClo: methylase-assisted hierarchical DNA assembly using a single type IIS restriction enzyme
por: Lin, Da, et al.
Publicado: (2018)

Evaluation of a Simple Low-cost Intervention to Empower People with CKD to Reduce Their Dietary Salt Intake: OxCKD1, a Multicenter Randomized Controlled Trial
por: O'Callaghan, Christopher A., et al.
Publicado: (2023)

The Pathogenesis of Staphylococcus aureus Eye Infections
por: O’Callaghan, Richard J.
Publicado: (2018)

Urinary Metabolomic Profile of Youth at Risk of Chronic Kidney Disease in Nicaragua
por: Hall, Samantha M., et al.
Publicado: (2023)

The Behaviour of Both Listeria monocytogenes and Rat Ciliated Ependymal Cells Is Altered during Their Co-Culture
por: Fadaee-Shohada, Mina J., et al.
Publicado: (2010)

Global Prevalence of Chronic Pain in Women with HIV: A Systematic Review and Meta-analysis
por: Povshedna, Tetiana, et al.
Publicado: (2023)

Molecular Analysis of the Interaction of the Snake Venom Rhodocytin with the Platelet Receptor CLEC-2
por: Watson, Aleksandra A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_o6cinomu5edmv2d38amc4mgu0m